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ABSTRACT 
Liver enlargement in rats resulting from oral adminis-
tration of pyrethrum has been observed in various laboratories. 
This study was undertaken to investigate the nature of this 
enlargem en t as well as resulting changes in hepatic drug metab-
olism. Oral administration of pyrethrum at 200 mg/kg for 13 
or 23 days resulted in decreases in h~patic DNA concentrations~ 
While total lipid concentrations were increased significantly, 
tha increases did not account for the enlargement. Protein 
concentrations of whole liver homogenates, 9,000 x g super-
natants and the 105,000 x g pellet were not different from 
controls, No significa nt c han ges occurred in hepatic water 
concentrations. Accompanying histologica l observations of 
the enlarged livers indicated cellular hypertrophy~ 
Significant decreases in hexobarbital induced hypnosis 
without conco~itant changes ir1 ba rbital induced hypnosis 
suggested a pyrethrum ca used alteration in hepatic drug metab-
olism. The activities of hepatic microsomal enzymes responsible 
for EPN detoxification, p-nitroanisole de~ethylation and hexo-
barbital oxidation were increased to 150, 173 and 241 percent 
of control, respectively. No significant increases were noted 
in the demethylation of aminopyrina or oxidation of L-tryptophan. 
Incre ases in liver weight, the detoxification of EPN and derneth -
ylation of p-nitroa n is~le were fou~d to be ~ose related. 
i -
IncLeased enzyme activities were observed at the lowest dose 
used of 85 mg/kg/d3y for 15 days. At a dose of 500 Tig/kg/day, 
liver w9ights and enzyme activities were increased continually 
during a 17 day period of treatment but returned to control 
leval within 7 days after cessation of treatment. NADPH-
cytochrome c reducta s e and P-450 concentrations were also 
increased. These data show that pyrethrum caus e s significant 
liver enlarg em ent with accompanying increases in microsomal 
drug metabolizing activity. They suggest a re-evaluation 
of the use of pyrethrum as a non-inducing insecticide. 
ii 
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I. INTRODUCTION 
In recent years increa3ing interest has developed in tha 
toxicity of the various classes of pesticides. The organo-
chlorine insecti~ides, and DDT in particular, are of growing 
ecological concern becauss of their widespread use and extreme 
persistence and the difficulty in evaluating the harmful effects 
of th ese low residues upon such parameters as the fertility of 
animals and fragility of bird eggs (O'Brien, 1967). The unre-
stricted use of these halogenated hydrocarbons in libor atory 
animal quarters has also been of concern (Fouts, 1963). Since 
enzyme induction can seriously affect the results of tests 
meant to evaluate the metabolism or the acute or chronic toxicity 
of drugs, care should be taken to exclud3 such insecticides 
from quarters of animals used in such studies (Conney, 1967). 
Another type ~ of insecticide, the organophosphates, fer example 
parathion and malathion, are inhibitors of cholineste~ase. 
Although they are rapidly hydrolyzed and thus are not persistent, 
the acute mammalian toxicity is high. 
Pyrethrum, an extract of the pyrethrum flo wer Chrysant hemum 
cinarariaefolium , contains four esters of complex alcohols and 
acids called pyrethrin I and II and cinerin I and II (S hepard , 
1939). As an insec t icid e , it has found wide use in agriculture, 
forestry, the home, and laboratory animal quarters because of 
its favorable properties. It demonstrates a low mammalian 
toxicity (Negherbon 1 1959), but at the same time has a high 
knockdown and kill rate on many classes of insects (Metcalf, 
195 5 ). Instability towards mild acid or alkali, and direct 
sunlight limits its persistence in the environment (Chen and 
Casid a , 1969). It has been generally assumed that pyrethrum 
7 
is safe for use .i n situations requiring a non-~nducing insscti-
ci de, such as in quarters housing animals undergoing ph3rma -
cological t esting (Fouts, 1963; Conn ey , 1967). Although no 
data was presented , the use of pyrethrum and piperonyl butoxide 
was recommen ded since there was no detected effect of these 
materials on hexobarbital induced narcosis or microsomal drug 
metabolizing enzyme activity . 
In examining the combin3d effe cts or DDT , pyrethr um , 
and pi pe ro ny l butoxide , Kimbrough et al (1968) found that 
--
pyrethr um , especially synergized pyrethrum, produced liver 
enlargement and cellular changes including margination and 
cytoplasmic inclusions . These changes were proportional to 
dosa ge and similar in ch arac ter to changes caus Gd by DDT. 
However, these studies were concerned only with morph ological 
chang es and did not include biochemical observations. Resu!ts 
from our laboratory of 90 day toxicit y studies cond u cted in 
rats e~ploying 25 percent of the oral LD50 also showed that 
pyrethrum, pipgronyl butoxide , tropital and sulfoxide, alone 
and in combination , caused liver enlargement ( Bond and Defeo, 
1967-1969). 
Liv er enlargement which may be indicative of abnormal 
structur al changes or other pathology often accompanies the 
8 
stimulation or inhibition of drug biotransformation (Conney, 
1967). Since the rate of hepatic drug biotransformation 
influences the resultant pharmacodynamic activity of a compound 
(Conney, 1967), it seemed important to examine the nature of 
the liver enlargement caused by pyrethrum, as well as possible 
a 1 t e r a t i on s i n t.h e h e p at i c b i o tr an s form a t i o n o f, d r u gs • 
Initial investigations were designed to explorn the physical 
causes of the enlargement, i.e., whethe~ due to edema, fat 
deposition, hyperplasia, or hypertrophy. Further studies 
examined the . nature and extent of alte~ations in hepatic bio-
transformation of drugs while additional work suggested a 
possible mechanism for such alterations. 
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II. REVIEW OF THE LITERATURE 
A. Pharmacology E.f. the P._yrethrin~_. 
Early work dealing with the toxicity of pyrethrum centered 
on its effects on mammalso The reported results varied with 
route of administration, species and vehicle used (Shimkin and 
Anderson, 1936; Ambro3e and Rob~ins, 1951; Negherbon, 1959; 
Bond and DeFeo, 1967-1969) •. The acute oral LD50 in rats for 
an 86~2 percent solution of pyrethrins was greater than 2.6 
g/kg. No mortality was observed in rats administered 1.6 g/kg 
subcutaneously (Ambrose and Robbins, 1951). Negherbon (1959) 
reported an oral LD50 for rats of 820 mg/kg and 1500 mg/kg 
for guinea pigs. A dose of 6-8 mg/kg was toxic to do~s when 
administered intravenously, suggesting that pyrethrum possessed 
a potent intrinsic toxicity. The acute oral LD50 in rats for 
a commercial solution of pyrethrum (20 percent pyrethrins, 80 
percent petroleum distillates) was 7200 mg/kg or the equivalent 
of 1440 mg/kg of pyrethrum alone (Bond and DeFeo, 1967-1969)0 
The acute oral LOSO in rats for pyreth~in I dissolved in 
dimethylsulfo xida was reported to be 260-420 mg/kg while that 
of pyrethrin II was greater than 600 Tig/kg. 
Administered orally in 6 doses over 12-54 hour periods, 
rats survived 450-2000 mg/kg of pyrethrin I and greater than 
2900 mg/kg of pyrethrin II (Cassida tl ~' 1971). Carpenter 
tl al . ( 1950) found tha-: rats were able to ingest over a 2L~ hour 
10 
period a quantity which was lethal if administered in a single 
dose and were able to maintain the intake for long periods 
without apparent injury. Bond and Dereo (1967-1969) noted 
that rats were able to tolerate a dcse of i' the oral LD50 for 
periods of 90 days without significant increases in mortality 
over that of controls. 
The chronic dermal toxicity of pyrethrum (20 percent 
pyrethrum, 80 percent petroleum distillates) to rabbits and 
the chronic vapor toxicity to mice, rats, guinea pigs and 
rabbits, as well as the associated histopathology of these 
animals is reported by the Office of the Surgeon General (1951, 
1952). Slight to mild skin irritation was observed in rabbits 
upon application of 1 ml/kg/day for approximately 30 days, 
with further applications progressing in severity. However, 
these same effects were produced by the solvent which was tested 
alone, suggesting that the effects were not due to pyrethrum 
but to the solve~t. Continuation of exposure to saturated 
vapors of pyrethrum extract for 5 weeks, 8 hours daily, 5 
days per week caused a 40 percent mortality in mice; preening, 
eye irritation and unthrifty appearance in rats; unthrifty 
appearance in guinea pigs; 3nd no apparent effects in rabbits. 
On a comparable basis, vapors from the solvent appeared to be 
more toxic than the extract and accounted for the toxicity of 
extract_ The histopathology of the tissues from these animals 
showed primarily vascular congestion which was more pronounced 
ih the lungs and kidneys than other tissues. These effects 
1 1 
were more severe in solvent treated anim a ls. 
Early studies by Feinberg (1934), Garratt and Bigger(1923), 
and IY1 c C o rd tl ~ ( 1 9 2 1 ) s h ow e d t hat s k i n con ta ct a n d i n ha 1 a ti on 
may cause allerg3nic attacks in sensitive people. Patients 
sensitive to ragweed developed allergic reactions to extracts 
of ground pyret~rum flowers; severe dermatitis and anaphylactoid 
reactions were also reported, IYlore recent studies using re-
fined pyrethrum suggested th a t there was no potential allergy 
to insecticides containing pyrethrins, as opposed to the 
unrefined material (Zucker, 1965). 
Structurally related new synthetic derivatives of pyrethrum. 
demonstrated toxicities similar to that of pyrethrum: allethrin 
(Ambrose and Robbins, 1951; Carpenter tl ~' 1950; Starr tl ai, 
195Da, 1950b), barthrin (Ambrose, 1963; IYlasri tl a~, 1964a, 
1964b), dimethrin (Ambrose, 1964; Masri tl al, 1964a, 1964b) 
and others (Chikamoto, 1964). Increased liver and kidney 
weights were noted in animals chronically fed barthrin or 
dimethrin (Ambrose, 1963, 1964) together with the reversible 
appearance of hepatic cytoplasmic inclusions (Masri tl ~' 1964b). 
many reviewers of this subject conclude that the effective 
and rapid knockdown action of pyrethrum in insects results 
from an initial impairment of neuromotor systems (Shepard, 
1951; Roeder, 1953; Metcalf, 1955; Negherbon, 1959; O'Brien, 
1967). Earlier studies with arthr opod nerves showed that 
direct application of pyrethrum caused initial e xcit a tion fol-
lowed by block (Ellis ot ~' 19 42; L.0 1JJe ns t e i n , 1942; Welch 
and Gordon, 1947). Allethrin a nd other synt hetics act in a 
similar mann e r ca us ing repetitive disc harga, negative a fter 
pot e ntial and conduction block and ha ve be e n t e st e d in cock-
roach giant a xon fi bers (Nar a has hi, 19 62a, 196~b) 1 squid 
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giant axons (Narahashi and Andersor1, 19 67) and crayfish giant 
axons (Berteau~~' 1968; Camougis et~' 1971) with micro-
electrode techn~ques9 Pyrsthrum in low co nce ntrations will 
block crustace an syn ap ses (Schalle k and Wier s ma , 1948 ). 
However, the exa ct part of the syst em involved , central versus 
peripheral, i s a matter of controversy (Ke a rns, 1956). Pyre-
thrum does act on the sensory nerve . endings causing temporary 
paralysis, and further poisoning effects may occur from local-
ized action along the axon. Centrally , pyrethrum stimulates 
repetitive discharge of nerve cells and fibers and later 
results in paralysis. 
In contrast to the relatively numerous st udies with 
arthropods, little information exists on the direct action of 
pyrethrum on vertebrate nerve. The gro s s syndrome in mammals 
includes excitation, tremor and convulsion sugge s ting actions 
on the nervous system (Negherbon, 1959; Hayes, 1965). Camougis 
et al (1971) made a comparative study of the neuropharmacoloical 
basis of action of pyrethrins in arthropods and vertebrates. 
The results from isolated nreve preparations showed that spon-
taneously active ganglia , or the electrically stimulated 
peripheral nerve of the cr a yfish, wa s pa rticularly sensitive 
to the blocking effects of pyr e thr um, but ins en sitive tu lido-
ca~ne. In contrast: both the fro g ner ve a nd r a t nerve we re 
resistant to a cute block by pyrethrum but se ns itive to lidocaine. 
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These apparent differences could not be attributed to the 
vertebrate nerve sheath, as shown in de sheathe d nerve prepar-
ations, and suggested a possible basic difference in the mech-
anisms of action. In whole animal studies, ~ow do ses of pyre-
thrum, 1-10 ug/kg, disrupted and blocked electrical activity 
of the heart in .crayfish Luhile doses c:.s high as. 1000 mg/kg 
failed to stop the frog heart. 
The earliest work on the metabolism of pyrethrum in insects 
led to the sugg es tion and virtual assumption that hydrolysis 
of the ester group was a major metabolic route (Bridges, 1957; 
Chamberlain, 1950; Chang and Kearns, 1964; O'Brien, 1967; 
W i n t er i n g ham At ~ , 1 9 5 5 ; and Z e id ~t .51J:. , 1 9 5 3 ) • T he s e s tu d i e s 
had limited success because the radiolabeled compounds used 
had either low specific activity, were mixtures of isomers -.m 
were otherwise impure. 
Sever a l c14-labeled pyrethroids, stereochemical ly pure 
isomers of high activity, were recently synthesized (Nishizwa 
and Casida, 1965; Yamamoto and Casida, 1968). With these com-
pounds it was possible to show that allethrin, pyrethrin I, 
phthalthrin and dimethrin ~ere metabolized in living ho use -
flies and in ~}tro, in the housefly mixed-function oxidase 
system. Attack occurred at the trans-(major site) and cis-
(minor site) methyl groups of the isobutenyl side chain in the 
acid, forming in sucession, the corresponding hydroxymethyl, 
aldehyde, and 2cid compounds. No hydrolysis or attack on the 
. 
alcoholic part of the ester was detected (Yamam oto and Casida, 
1966; Yamamoto~~' 1969) 0 
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While there is some information about the metabolism of 
pyrethrin I and r e lat e d compo unds in houseflies, relatively 
little is known about its fat e in mam ma ls. The most recent 
work (Casida~ al, 1971) indica ted that in rats each of the 
principal metabolites of pyrethrin I and II retained the cycle-
propane e s ter lLnkage and ~as formed by modifica tion of both 
the acid and the alcohol moieties. The sites of attack were 
the trans-methyl group on the side chain of the acid and the 
double bond of the alcohol side chain. However, with allethrin, 
there was also hydroxylation at the methylene group of the 
allyl side chain and hydrolysis of the central ester linkage~ 
W!1en barthrin and dim e thrin was fed to rabbi ts, chrysanthemumic 
acid and the corresp onding alcohols or acids were recovsred 
from the urine (IYlasri ~ ~' 1964), though the major part of 
the metabolite was not identified~ 
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B. Live£ Enlarg em ent 
The physiological significance of enhanced liver growth 
and function in animals treated with various drugs has not 
yet been determined and it is not clRar whet her these ~ffects 
are harmful or beneficial (Conney, 1967). While erlargement 
of the liver is generally regarded as a pathological phenomenon 
(Kunz, 1966), the concern lies with the increase in relative 
liver weight in the absence of histopatholoical effects indic-
ative of liver dam a ge (Golber g , 1964). 
Organ weight is related to body weight according to the 
principle of allrn ,1 etry, so th a t a log-log pl o t of body wE i ght 
against liver weight yields a str a ight lin e {Addis and Gray, 
1950)~ Published data for the rat varies somewhat in this 
respect (Zumoff and Pachter, 1964; Setnikar and Magistretti, 
1965), and attention has been called to the error introduced 
15 
by comparisons of organ weights of rats when the body weights 
are consistently different (Setnikar and Magistretti, 19 65 ). 
Ho1.1Jever, data f o.r some strains of rats in com m on use t evealed 
satisfactory liver to body weight correlations at 13 and 25 
months (Sherm an , 1963)~ 
Phe ~obarbital increased drug-metabolizing activity in 
hepatic microsomes and exerted an anabolic effect on the liver 
which resulted in a 20-40 percent inc~ease in microsoma l pro-
tein per g liver. (Conney .§.l tl' 1960; Conney and Gilman, 1963) .. 
In contrast, 3-methylcholanthrene, a polrcyclic hydrocarbon 1 
stimulated liver growth and the synthes;s of total liver 
protein with little or no increase in the concentration of 
microsomal protein (Conney and Gilman, 1963; Arcos .§.l al, 
1961). The~e studies suggested that the ability of polycyclic 
hydr~carbons to stimulate liver growth was .related to their 
ability to induce microsomal enzyme formation (Arcos et al, 
. . --
1961) . Some drugs, such as chloroform, halothane and penthrane, 
caused liver enlargement without enhanced liver microsomal 
activity and the enlargement was showr. biochemically not to 
be due to · fat or ede ma (Kunz, 1964; Kunz .§.l tl, 1966). In a 
structure activity relationship study of pheno l derivatives, 
no corr e lation was found between the enhance me nt of liver 
growth and stimulation of aminopyrine demethylat ion or hexo-
barbital oxidation (Golber g , 1964; Gilbert et tl' 1969). 
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In view of the diversified effects of various drugs on the 
liver , it was of interest to determinG what biochemica l effects 
would be associated with liver enlargement due to pyrethrum . 
17 
III. EXPERIMENTAL 
A. Animals 
Sprag ue -Dawley random bred, male albino rats obtained 
from Charles River Breeding Laboratories, Wilmington, Ma ss ., 
weighing 100-300 g were used. The animals were housed in 
quarters maintained at 21-23°C with room lights on alte~nating 
12 hour light-dark cycles. Commercial laboratory chow and water 
were allowed ad libitum. Animals were u~ed no earlier than 
5 days following receipt from the supplier. Pyrethrum and 
corn oil were administered by oral intubation, while all other 
drugs were administered intraperitoneally. 
8.- Materials 
Analytical grade chemicals or equivalent were used throu9h-
out this study. Cofactors (NADP, NADPH and glucose-6-phosphate) 
and s u b s tr at es ( c y t o ch r om e c , L - tr y p t op ha n a.n d p - ch 1 or om et h y 1-
a nil in e were obtained from Calbiochem., Los Angles, Calif. or 
from Sigma Chemicals, St. Louis, Mo. Crystall in e bovine serum 
albumin was obtained from Armour Laboratories, Kankakee, Ill •• 
Drugs used were obtained from their respective man u fa~turers. 
Pyrethrum, 20 percent mixture of pyrethrins I and II and 
cinerin I and II in corn oil, was obtained from the Mclaug hlin 
Gormley King Co., Inc., Minneepolis, Minn •• Mazola corn oil was 
used as the control vehicle. 
c, Me asurement Ef Dr ug-Induced Narcosis 
Duration of hexobarbit a l induced narcosis was taken as 
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the interval between injection of the drug and the return of 
righting reflex, the endpoint of which was determined according 
to Wenzel and Lal (1959) using two rightingswithin 30 sec. 
Barbital induced narcosis was measured as the time of loss and 
the return of righting ref lex. The interval between injection 
of the drug and loss of righting reflex was designated as onset 
of narcosis. 
D. Preparation E.f Rat Liver ~ernatant Fractions 
Rats were guillotined 24 hours subsequent to th e last 
administered dose of pyrethrum or corn oil. Livers were 
perfused i.n situ with ice-cold 0.15 M KCl and were homogenized 
in 2-3 volumes of ice-cold 0.1 M phosphate buffer (pH 7.4) at 
1000 RPM for 1 min in· a coaxial glass homogenizer with teflon 
pestle. The 9,000 x g supernatant fraction ~as obtained by 
0 
centrifugation at 0 C for 30 min (10,000 rpm in a model 8-60 
International Preparative Ultracentifuge (IEC) #874 rotor). 
0 Portions of this fraction were then stored at -20 C until assayed. 
The 105,000 x g pellet was obtained by centrifuging 
0 
aliquots of the 9,000 x g supernatant at 0 C for 2 hours in an 
IEC preparative ultracentrifuge, #A-170 rotor, 37,000 rpm. 
This pellet was dispersed in 0.1 M phosphate buffer (pH 7.4) 
and stored at -20°c until assayed. In instances when only the 
protein concentration of this pellet was de t erw. ined, the pellet 
was digested in 0.5 M NaOH and assayed. 
E. Analytical Procedures 
. 
All incub ations were carr ied out in 2 Dubnoff metabolic 
shaker under ai.r. All absorbance re a dings were determined in 
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a Beckman DB-G spectrophctometer. 
1. Determination of Hepatic ~ater Concentrations 
Four ml aliquots of whole liver homog enate equal to 1.0 g 
of liver were placed in 50 ml tared beakers and frozen in 
liquid nitrogen~ The samples were lyophilized for 40 hours 
at 0.5 mm pressure with no external heat in a Virtis LyophilizDr, 
Research Equipment, Gardner, N.Y •• Water content was determined 
as the percent loss in ~eight. 
2. Detern:2-nation of Hepatic Total Lipids 
The method of isolation of total .lipids was essentially 
that of Folch ~ ~l (1957) with modifications by Sperry and 
Brand (1955) and further modified by using lyophilized tissue. 
Lyophilized liver tissue, 1 g equivalent of whole liver, was 
powdered with e glass stirring rold and mixed for 20 min with 
20 ml of a 2:1 chloroform-methanol mixture. The extract was 
suction filtered into 50 ml centrifuge tubes and mixed witt1 
4.0 ml of a 0.04 percent aquEous CaC1 2 solution~ to remove 
interphase fluff. The tubes were capped and centrifuged. The 
upper phase was aspirated carefully to avoid losing any of the 
lower phase •. 
The inside wall of the tube was rinsed with 3.0 ml of an 
upper phase solvent mixture obtained from the separation of 
an 8:4:3 mixture of chloroform, methanol and ~ater. The upper 
layer was then aspirated and the procedure repeated twice. 
The remaining extract was diluted with methanol to form one 
phase and ~ransferred to tared 50 ml Erlenmeyer flasksc The 
0 
solution was evaporated to dryne ss at 35-40 in a stream of 
nitrog en to prevent oxidation of lipids. The res id ue was 
dryed overnight in a vacuum desicat~ containing dri-rite. 
3. Determination of Hepatic DNA 
20 
The extraction of DNA was carried out according to the 
procedure of Schneider (1945), while the method of ~easurement 
was that of Burton (1956). 
One ml of whole liver homogenate was mixed with 2r5 ml 
of ice-cold 10 percent trichloroacetic acid (TCA) 1 and centri-
fug ed. The supernitar1t was decanted and discarded. The residue 
was suspended in 2.5 ml of TCA and centrifuged and the super-
natant decanted and discarded.. This procedure removed acid 
solu ble phosphorous compounds. 
The tissue residue was suspended in 1.0 ml of wEter, and 
4.0 ml of 95 percent ethanol added. The mixture was centri-
fuged and the supernatant was decanted and discarded. The 
resi due was resuspended in 5.D ml of ethanol followed by centri-
fugatio~ and disposal of the supernatant. This procedure 
removed residual TCA~ The residu e was then boiled 3 times for 
3 min each in 5.0 ml of a 3:1 mixture of ethanol and ethyl 
ether, followed by centrifuging and discarding the supernatant 
to remove phospholipids. 
The re sidue , resuspended in 1.2 ml of water, and mixed 
with 1.3 ml of cold TCA, was centrifuged and the supernatant 
discarded. 
The r esidue was suspended in 5.0 ml of 5 percent TCA, 
heated far· 15 min at 9D 0 c, cooled and centrifu gs d . The super~ 
natant was decanted and saved. The residue was ~ <.,J s pended in 
2,5 ml of 5 percent TCA, centrifuged and the supernatant 
decanted~ The TCA extracts were combined to form a nucleic 
acid extract (7.5 ml). 
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In the development of a chromophore, equal volumes of 
TCA extract and 1o0 N perchloric acid were mixed. To 2 ml of 
this mixture was added 2.0 ml of diphenylamine reagent con-
taining acetaldehyde. This reagent was prepared by dissolving 
1.5 g of diphenylamine in 100 ml of glacial acetic acid and 
adding 1.5 ml of concentrated sulfuric acid. On the day of 
use, D.1 ml of aqueous acetaldehyde (16 mg/ml) was added for 
each 20 ml of reagent required. A reagent blank was prepared 
containing an equal valuma of 5 percent TCA and 1.0 N perchloric 
acid. 
The above mixtures were incubated after capping .at 30°C 
for 16-20 hours and read at 6QO nanometers verses the reagent 
blank. 
4. Determination of Hexobarbital Oxid3tion 
The oxidation of hexobarbital was estimated by measuring 
the disappearance of substrate using the method of Cooper and 
Brodie (1955). One ml of 9,000 x g supernatant was added to 
an incubation mixture containing 2.12 umoles of hexobarbital, 
25 umoles of glucose-6-phosphate, 12.0 umoles of magnesium 
sulfate, 100.0 umoles of nicotinamide, D.65 umoles of NADP and 
sufficient 0.1 M phosphate buffer, pH 7.4, to make a final 
volume of 4.0 ml~ Two parallel flasks, one containing 100 ug 
of hexoba~bital with boiled tissue and the other containing 
tissue but not hexobarbital, wa re incub a t e d at 37°c for 30 min 
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and carried through the procedure to serve a s bla,k . 
The barbiturate was extracted and quantitatively me asured 
accordi n g to a procedure described by Brodie~~ (1953). 
The above incubation mixtures were tran s ferred to 50 ~l centri-
fuge tubes containing 1 g of sodium chlorid e and 30 ml of 
petroleum ether (technical grade, B.P. 37-47°c and purified by 
washing with 1 N NaOH, 1 N HCl and 2 washings with water) con-
taining 1.5 pe r cent isoamyl alcohol. Phosphate buffer, 1.5 ml, 
pH 5.5 was ad ded. The tubes were capped, shaken for 45 min 
and centrifuged. Twenty ml aliquots of the petroleum ether 
layer were tiansfe r red to 50 ml centrifuge tu bes containing 
10 ml of phosphate buffer, pH 11.0. The tubes we re capped, 
shaken for 10 min and centrifuged. The upper phase was aspir-
ated. The absorbance of the unmetabolized barbiturate remaini ng 
in the buffer layer was determined at 24 5 nanometers versus 
pH 11 buffer. The concen~ration of the unmetabolized barbit-
urate in the sample extract was compared with a stand a rd solution 
prepared by dissolving 10 mg of the barbiturate in sufficient 
distilled water to make 100 ml. A te n fold dilution was then 
made with pH 11 buffer and the abso r bance of the resultant 
solution (100 ug/ml) obtained. Recovery of the barbiturate 
added to the homogenate was 90-100 perce nt. 
5. Determination of Serum Level of Hexobarbital 
Rats were sacrificed by guillotine imm a diately upon 'return 
of righting reflex and free flowing blood collec t ed in conical 
centrifuge tubes on ice . Serum was obtained by centr ifugation 
. . 
fo r 10 min in a clini ca l centrifuge . The ex t r a ct i c procedure 
of Brodie et~ (1953) was performed as described in the 
dstermination of hexobarbital oxidation except that 2 ml of 
serum, and 4 ml of pH 11 buffer was used. 
6. Determination of Aminopyrine N-Demethylase 
The N-demethylation of aminopyrine was estimated by 
measuring the formation of formaldehyde according to the 
method of McMahon and Easton (1962). 
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One ml of 9,000 x g supernatant was added to an incubation 
mixture containing ·10 u~oles of aminopyrine, 45 umoles semi-
carbazids, 15 umoles glucose-6-phosphate, 2 umoles NADP, 50 
umoles magnesium chloride, 50 umoles nicotinamide and sufficient 
0.1 M phosph3te buffer, pH 7.4, to make a total volume of 5.0 
ml. Parallel incubation flasks containing 1.32 umoles of 
formaldehyde (standard) in place of substrate and distilled 
water (blank) in place of substrate were carried through the 
entire procedure. 0 Incubation was carried aut at 37 C for 60 
min. A second experiment was performed in which the incubation 
period was altered. 
The samples were ae~ayed for formaldehyde in the following 
manner. The flask contents were poured into 15 ~l centrifuge 
tubes containing 4.0 ml of 10 percent zinc chloride solution 
prepared with CO -frea water. After mixing, 2.0 ml of a sat-
2 
urated solution of barium hydroxids was add~d and the samples 
were again mixed. The tubes were centrifuged for 10 min and 
5.0 ml aliq~ots of clear supernatant were transferred to 15 
ml centrifuge tubes containing 2.0 ml of double strength Nash 
reagent (0.04 M acetylacetone in 0.4 M ammonium acetate-0.1 M 
acetic acid)o The contents were mixed and the tubes heated 
0 
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in a water bath at 60 C for 30 min. Absorbance was determined 
at 410 nanometers versus a tissue blank. The amount of form-
aldehyde formed was determined by comparison with the absorb-
ance of standards. 
7, Deterinin.ation .9i_ p-Chloro-N-methylaniline N-Dernethylation 
Determination of p-chloro-N-methylaniline (PCMA) was 
determined by assaying of p-chloroaniline formed according 
to the procedure of Kupfer and Bruggeman (1966) as modified by 
Fuller et~ (1969). IncubatiJns were carried out at 37°c 
for 30 min in media containing 3 umoles PCMA, 1 . 6 umoles NADP, 
16 umoles glucose-6-phosphate, 30 umoles MgC1 2 , 20 umoles 
nicotinamide, 120 umoles phosphate buffer , pH 7~4, and 9,000 
x g rat liver supernatant containing 2-4 mg protein. The 
reaction was stopped by the addition of 3.0 ml p-dimethyl-
aminobenzaldehyde (20 mg/ml in 1 N H2so 4 ). Incubation flask 
contents were mixed and centrifuged at 8,000 x g for 30 min. 
Absorbances were read at 445 nanometers and were corrected for 
abso_bance of blanks. The amount cf p-chloroaniline formed 
was determined by comparison with standard solutions of 
p-chloroaniline . 
8 . Determination of O-·Ethyl,0-(4-nitropheng)phenyl.Ehos-
phonothioate Detoxification and p-Nitroanisole 0-p~methylation 
The detoxification of 0-ethyl, 0-(4-nitrophenyl)phenyl-
phosphonothioate (EPN) and the 0-dem~thylation of p-nitro-
anisole was estimated by measuring the formation of p-nitro -
phenol according to the.method of Neal and DuBois (1965), as 
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suggested by Netter and Seidel ( 1965)q 
To an incubation mixture containing 1.3 umoles NADP, 
3.3 umoles glucosa-5-phosphate, 0.2 ml EPN-buffer and sufficient 
water to make a t~tal volume of 0.8 ml was added D.1 or 0.2 
ml of 9,000 x g suparnatant, diluted 1:1 with 1.15 percent KCl 
contai ning 0.25 percent nicotinamide. The EPN-buffer was 
perpared by dissolving EPN, 2.0 mmoles in 1:4 ethanol, propylene 
glycol and adding 0.5 ml of this solution to 5 ml of 0.1 m 
phosphate buffer , pH 7.8. 
Incubation was carri ed out at 37°C for 60 min. The reaction 
was terminated by adding 2.5 ml cold acetone to the reaction 
flask. The flask conten~s were pcured into centrifuge tubes 
and 0.2 ml glycine-NaOH buffer (0.5 m, pH 9.5) was added. The 
tubes were centrifuged and the supernatant read at 410 nano-
meters versus blank to which tissue had been added at the 
termination of incubation. The amount of p-nitrophenol formed 
was determined by comparison with the absorbance of blanks. 
The ~pocedure for measuring 0-demethylation of p-nitro-
anisole was the same as above except that p-nitroanisole, Oo9 
mmoles was substituted for EPNo 
9. Estimation of Protein 
Protein content W3S determined by the colorimetric pro-
cedure of Lowrey~ <3.l (19 51 ) with minor mJdifications. · ·An 
aliquot of 0.4 ml of microsomal fraction of an aliq uo t of 0.2 
ml of 9,000 x g supernatant was added to a 15 ml t e ~t tube 
containing 10 ml of 0.5 m NaOH . The tubes were he -e d in a 
water bath at 60°c for a complete dissolutio n . s · .,. - :rd 
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solutions of crystallin bovine serum albumin and a blank of 
0.5 m sodium hydroxide were carried through the entire procedure. 
When dissdution was complete, a 0.3 rnl aliquot was removed and 
placed into a tube containing 1.0 ml of 0.5 m NaOH. To this 
was ad d e d 5 m 1 o f r ea g e n t 11 A " ( p rep a r e d b '/ the ad d i t i on o f 1 • 0 
ml of 1 percnet .cupric sulfate solution and 1.0 ml of 2.7 
percent potassium tartrate s~lution to 100 ml of 2 percent 
sodium carbonate solution). After mixing, the tubas were 
allow ed to stand at room temperature for 20 min. At this time, 
0,5 ml of reagent 11 8 11 • (prepared by diluting commercial Folin-
phenol reagent solution ~ith an equal volume of dis~illed water) 
was added to each sample and mixed. The samples were allowed 
to stand at room temperature for 40 min to develop color~ 
The absorbanca of the solution was determined at 500 nanometGrs 
versus a reagent blank. The concentration of protein was 
determined by comparison of this absorbance with that of 
standards. 
10. Deter mination Ef L-Tryptophan E_l'.rrolase ~tivity 
L-tryptoph3n pyrrolas8 activity was estimated through 
assay of kynurenine formed according to th2 methoj of · Knox 
and Mehler (1950). 
Incubations were carried out at 37°c for 60 min in media 
containing 7.5 mmoles L-tryptophan, 2.0 ml of 0.1 m phosphate 
buffer, pH 7.0, and 9,000 x g supernatant fraction containing 
10-20 mg of protein in a total volume of 4.0 ml . 
The reaction was stopped by the addition of 2.0 ml of 
~5 percent rnetaphosphoric acid. The flask contents were 
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centrifuged, and a 3.0 ml aliquot was neutralized with 1.0 ml 
of 1 N NaOH. The samples were read at 365 nanometers versus 
a blank. The amount of kynurenine formed was calculated 
3 from the molar extinction coeffecient of 4.53 x 10 • 
11. Det ermination of NADPH-Cytochrome c Reductase Activi_!:y 
NADPH-cytochrome c reductase activity was determined 
according to the procedure of Dahlner (1963), from the rate 
of reduction of cytochrome c through assay of the optical 
0 
density of the reduced cytochrome at 550 nanometers at 30 C. 
Three ml of reaction mixture contai ning 0.65 umoles NADPH 
and 0.5 u~oles cytochrome c in 0.33 mM KCN-phosph3te buffer 
(0.5 M, pH 7.4) were placed in the reference and sample cuvattes~ 
The r eaction was started by adding 0.1 ml of microsomal 
suspension containing 1-2 mg protein/ml to the sample cuvette. 
The contents were mixed and recording was started immediately. 
The reaction rate was linear for 3-5 mino 
The amo'...lnt of cytochrorie reduced was calculated from the 
3 
molar extinction coefficient of 18.5 x 10 for the reduced 
minus the oxidized cytoch~ome c. 
12. Determination of £Q.-Binding Pigmen.t (£:1.-450) Concentration~ 
The determination of P-450 concentrations was based on the 
recording of a differen:e spectrum generated by microsomes 
treated with carbon monoxide as specifiad by Dahlner (1g63). 
A reaction mixture of 6.D ml was prepared containing 10-
20 mg of microsomal protein and 0.05 m phosphate buffer, pH 7.4, 
to which sodium dit~ionite, 1 mg/ml, had bee~ add e d to reduce 
the microsomal pigments. Three ml of the reacti o ~ mixture was 
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IV. RESULTS 
Physical Parameters E..f. Liver Enlargement 
For characterizing the physical aspects of liver enlarge-
ment, rats were ~dministered pyrethrum, 200 mg/kg/day orally 
for 23 days and sacrificed 24 hours subsequent to the last 
administered dose. The effects of pyrethrum on relative 
liver weights, water concentrations and total lipids are shown 
in Table 1. 
Relative liver weights of the pyrethrum treated animals 
increased 23 percent as compared to controls, while body 
weights and hepatic water concentratio,s were unaffected by 
the tre atment . Although the increase in total lipids is 
statistically significant at the P: .05 level, it does not 
account for the total increase in liver weight. 
In Table 2 are shown the effects of pyrethrum administered 
for 13 days at 200 mg/kg/day on relative liver weights, 
protein and DnA concentrations. Relative liver weights of t he 
pyrethrum treated animals were increased 30 percent over that 
of controls. Although the body weight of the pyrethrum 
treated animals was statistically greater at the P= .01 level, 
it dosen't completely account for the increase in liver 
weights, since the relative liver weights were significantly 
great er . Protein concentrations of whole liver homogenates, 
9,000 x g supernatants anj 10 5 ,000 x g pellets were not 
30 
TABLE 1. Effect of pyrethrum, 200 mg/kg/day orally for 23 
days 1 on liver to body weight ratio, total lipid 
and water content 
Mean ±.SE (N) 
Control Treated 
Body l>Jeight ( g) 325.0 ±. 10.0 (6) 316. 0 ±. s.o (6) 
Liv er l>Jei.ght ( g) -
Body Weight (kg) 42.2 ±. 0.5 (6) 52.1 ± 1.8** (6) 
Percent Water 63,9 ±. 0,4 (6) 62.7 ;±. 0.9 ( 6) 
Total Lipids 
rr:g/g liver 44.6 ±. 1 • 1 (6) 49.7 .:±. 1.6* (6) 
---
*Pl:0.05 1 **Pf0401 as compared to control values, 
TABLE 2. Effect of pyr e thrum, 200 mg/kg/day orally for 13 days,_ on liver to body 
weight ratio, protein and DNA 
!Ylean ± SE (N) 
Control Treated 
Body Weight (g) 147.0 ± 2.o.9 ( 8) 163.7 ±. 2.9 ** (6) 
Liver Weight (g) 
Body Weight (kg) 46 .• _o ;±. 0. 9 ( 8) 59.8 ±. 1.3 ** (6) 
Protein (mg/g liver) 
( 7) . ( 6) whole homogenate 99.8 ±. 3.3 99.7 ±. 1.5 
9~000 x g supernatant 70.5 .+ 1. 6 
- ' 
( 7) 71.-1 .±. 2 •. 4 ( 6) 
105,000 x g pellet 18.9 :±.. 0.7 (6) 19 0 7 ±. 0.7 (6) 
DNA (OD 600/g liver) 1 • 8 2 :±.. 0 ... 1 5 (.7 ) 1.30 .±. 0~02** (6) 
**P~0.01, as compared to control values. 
tN 
...... 
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significantly different from controls. DNA concentrations 
d3creased by 29 percent, suggestive of hypertrophy. While 
a combination of hypertro?hY and hyperplasiacould have 
yielded the same results, microscopic examination of liver 
sections showed a predominance of hypertrophy. 
Barbiturate Narcosis 
In order to determine the effects of pyrethrum on hexo-
barbital and barbital induced narcosis, rats were administ ere d 
pyrethrum, 200 mg/kg/day or an equal volume of corn oil, 
orally for 6 days. On day 7, approximat e ly half of each 
group were administered hexobarbital, 135 mg/kg intra-
peritoneally, while the other half of each group was given 
barbital, 200 ~g/kg intraperitoneally. The duration of 
narcosis was recorded, as well as onset in the case of barbital. 
Table 3 sh ows the results of this study. 
The duration of hexobarbital narcosis was decreased by 
approximately 50 percent in the pyrethrum treated animals 
while the onset and duration of barbital narcosis was un-
affected. 
In earlier studies (Table 4) pyrethrum administerad in 
isoparaffinic oil verses a corn oil treated group, caused a 
similar decrease in the duration of hexobarbital narcosis. 
Hexobarbital serum levels at return of righting reflex were 
measured and were not sign±ficantly different (P=0.05) 
from control lev e ls. 
In Vitro Metabolic Studies 
The 9,000 x g supernatant fr act ions of liver homogenates 
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TABLE 3. Effect . of pyrethrum, 200 mg/kg/day orally for 6 
days, on hexobarbital and barbital induced narcosis 
--
Hexo barbitaJ. 
135 mg/kg 
Barbital 
200 mg/kg 
onset 
Narcosis 
Min+ SE (N) 
Control Treated 
4008 ±. 1.7 (6) 22.7 ±. 1.1** 
121.-5 ±. 5.4 (10) 128 •. 1 .±. 5.3 
48.7 ±. 2.6 (10) 43.5 .±. 1, _4 
**P:OaD1, as comp aredto control values. 
(7) 
( 1 1 ) 
( 1 1 ) 
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T /l.BLE 4. 1 Effect. of pyrethrum , 200 mg/kg/day orally for 12 
days, on hexobarbital 2 induced narcosis and hexo-
barbital serum levels at return of righting reflex 
IYlean ±. SE (N) 
Narcosis (min) 
Serum Levels (ug/ml) 
Control 
58.6 ± 4o7 (6) 
72.3 .±. 5.5 (6) 
Treated 
26.3 ±. 2.5** (6) 
66.7 ±. 4 .. 7 (6) 
1Pyrethrum administered as 20 percent solution of pyr e thrins 
in isop a raf f inic oil. Controls received an equal volume 
of corn oil. 
2Hexobarbital, 150 mg/kg intraperitone a lly. 
**P60~D1, as compared to control values. 
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prepared from animals used in the determination of parame ters 
of liv er enlargement were employed in preliminary studies of 
microsomal drug metabolism. Rats that had been treated with 
pyr ethrum , 200 mg/kg/day for 23 days were examined for changes 
in in vitro a~inopyrine demethylation and hexobarbital 
oxid ation (Tabl e. 5)., Protein concentrations of the 9,000 x g 
supernatants were not significantly (P=0.0 5 ) altered by the 
pyrethrum treatment. Hexobarbital oxidation was increased 
to 268 percent of control levels in the pyrethrum treated 
group. However, the N-demethylation of aminopyrins was not 
significantly altered. 
Further investigation of the in vitro metabolism of 
aminopyrin e showed the production of formaldehyde by this 
fractio n was not linear for 60 min (Fig ure 1). However, 
when portions of the above prepar ed samples were combined and 
assayed in duplicate determir1ations for the production of 
formaldehyde at 10, 20, and 30 Tiin there were no significan~ 
differences between pyrethrum treated and control animals. 
The production of formaldehyd9 was found to be linear for at 
least 30 min. 
In a prior study of in vitro metabolism, rats that were 
admini stered pyrethrum in isoparaffinic oil, 200 mg/kg/day 
for 12 days, showed no aiteration in the N-demethylation of 
p-chloro-N-methylaniline (Table 6). However, these same 
animals showed a decrease in hexob a rbital induced narcosis 
(Tabl e 4). 
The investigation for alterations in in vitro drug 
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TABLE 5. Effect of pyr eLhrum , 200 mg/kg/day orally for 23 
days, on aminopyrine demethylation and hexobarbital 
oxidat ion by 9,000 x g supernatants 
Mean 
.±. SE (N) 
Control Treat ed 
Protein, mg/g liver 75.1 1.9 (6) 74.2 
.±. 1.4 ( 6) ;±. 
Aminopyrine 
HCHO formed 
nm ole s/mg protein/50 min 44.8 
.±. B.1 (6) 52.6 .±. 4.2 ( 6) 
Hexobar bital 
nmoles/mg protein/30 min 30.3 ±. 6.9 (6) 81o2 .±. 3.01<-* ( 6) 
*"*·P:O. 01, as co.11pared to control values. 
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TABLE 6. 1 Effect of pyrethrum , 200 mg/kg/day orally for 12 
days, on p-chloro-N-methylaniline demethy lation and 
aminopyrine de methy lation by 9,000 x g supernatants 
---~·--------
p-Chloro- N-meth ylaniline 
p-chlo roaniline formed 
nmoles/mg protein/30 min 
Aminopyrin e 
HCHO formed 
nmol es /mg protein/60 min 
!Ylean + SE (N) 
~~--~~- ~----~ 
Control Tre a t ed 
50.8 ;!:. 5o2 (8) 
45.9 ;±. 5-.9 (6) 59.9 ±. 6.9 (6) 
1Pyrsthrum administered as 20 percen t solution of pyr eth rins 
in isoparaffinic oil. Controls received an equal vol ume 
of corn oil. 
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metabolism was continued with examin3tion of EPN detoxification, 
and p-nitroanisol 0-demethylation. In Table 7, rats that had 
been treated with pyrethrum, 200 mg/ kg/day orally for 13 days, 
showed significant increases in the detoxification of EPN, 
and demethylation of p-nitroanisol, 148 and 176 percent of 
co ntrol levels, respectively. Hexobarbital oxidation was 
increa sed to 173 percent of control le vels. 
The in vitro metabolism of EPN and p-nitroanisole by 
9,000 x g supernatants were chosen as indicators of microsomal 
drug metabolism in studies d3signad to establish a dose-effect 
relations hip as well as the time course and reversibility of 
the pyrethrum caused liver changes. 
In a dose-effect study, groups of 4 rats were administered 
pyreth rum , 85,200 or 500 mg/kg/day for 15 days. An additional 
gro~p of animals was administ8red corn oil. Figure 2 
graphically relat es the informatio~ from the tables and shows 
the results of this study. 
As shown in Table 8, in comparison to control levals, 
administration of 85 mg/kg of pyrethrum caused no significant 
liver enlargement, while 200 and 500 mg/kg caused 24 and 37 
percent increases. Protein concentrations of whole liver 
homog enates , 9,000 x g supernatants, and 105,000 x g pellets 
were not significan tly different from controls at all dosages 
(Tabl e 9). As se e n in Table 10, the metabolism of EPN and 
p-nitroani sole was significantly incre ase d at the 3 doses 
used in the pyrethrum treated animals. With increasing 
dosag e , the metabolism of EPN was increas ed to 124, 140 or 
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TABLE 7. Effect of pyrethrum, 200 mg/kg/day orally for 13 days, 
on EPN detoxification, p-nitroanisole demethylation 
and hexobarbital oxidation by 9,000 x g supernatants 
IYlean ±. SE ( N) 
Control Treated 
EPN 
p-nitrophencl formed 
nmoles/mg protein/60 min 13.4 ±. 1o4 ( 4) 19.B ±. 1.4** ( 5) 
p-Nitroanisole 
p-nitrophenol formed 
nm oles mg protein/60 min 16 .. 5 ±. 1 .. 3 (4) 29.0 ;:!:. 2. 2*-l<· (5) 
Hexobarbital 
nmole s /m g protein/30 min 27.6 ±. 2.0 ( 7) 4 7 .• .7. ± 2. 9.*-l<- -( 6) 
**Pf0.01, as compared to control values. 
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TABLE 8. Effect of pyrethrum, three dose levels orally for 15 
days, on body weight and liver to body weight ratio 
----~ 
Dose Mean ±. SE (N) (mg/kg) Body Weight (g) Liver7Body (g/kg) 
Control 315 .. 0 ± 24.0 (3) 43.8 ±. 1.8 (3) 
85 318.5 ±. 22.1 ( 4) tf4. 1 ±. 0.9 (4) 
200 299.8 ±. 8.8 (4) 51.6 ±. 1.9* (4) 
500 301.0 
.:±. 10.7 (4) 59.1 ±. 2.4** (4) 
*P~0.05, **P~0.01 as compared to control values. 
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TABLE 9. Effect of pyrethrum, three do s e levels orally for 
15 days, on liver protein concentrations 
Fraction Dose Protein 
(mg/kg) mg/g liver ±. SE (N) 
Whole Homogenate Control 110.4 ;:!:_ 5.3 (3) 
85 119.6 ±. 1.8 ( 4) 
200 115.6 ±. 1.9 (4) 
500 123.5 ±. 2.0 ( 4) 
9,000 x g Supernatant Control 70.2 
..±.. D.6 ( 3) 
85 72.6 ±. 2.8 (4) 
200 70.0 ±. 1.5 ( 4) 
500 75.3 ±. 1.1** ( 4) 
105,00 0 x g Pellet Control 15.5 ±. D.7 (3) 
85 14.0 ±. 0.3 ( 4) 
200 13.8 
..±.. 0.9 ( 4) 
500 15.5 ±. 006 (4) 
**P::D.01 as compared to control values. 
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TABLE 10. tffect of pyrethrum, three dose levels orally for 
15 days, on the detoxification of EPN and demethyl-
ation of p-nitroa nisole by 9 1 000 x g supernatants 
Dose p-nitrophenol for me d 
(mg/kg) nmoles/mg protein/60 min 
.±. SE (N) 
EPN p .-N i tr o an is o l e 
-- -------
Control 9.2 ± 0.4 ( 3) 7.5 ±. 0.5 ( 3) 
85 11.4 ± 0,8* ( 4) 10.1 ±. 0.6* (4) 
200 12.9 ±:. Oc4** (4) 13. g ±. 1.2** ( 4) 
500 16., 0 ±. 1.2** (4) 15.9 ±. 1.3** (4) 
*Pf0.05, ·**P~O. 01 as compared to control values. 
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174 percent of controls while the metabolism of p-nitro-
anisole was increased to 136 7 187 or 21j percent of controls. 
Figure 2 sho~s that with increasing dosage, these parameters 
increased in an app rox imately logarithmic fashion. 
In order to examine the time cours e and reversibility 
of these changes, groups of 4 rats were administered. pyrethrum, 
500 mg/kg/day f.or 4, 7 and 17 days and sacrificed 24 hours 
subsequent to the last administered dose. An additional 
group was treated for 17 days and sacrificed on the 24th da y. 
Tables 11 to 13 and Figure 3 show the ~esults of this study 
As seen in Table 11, with increasing duration of treatment, 
relative liver weights of the pyrethrum treated ani mals were 
increased ~o 148, 15e or 160 percent of control levels after 
4, 7 or 17 days of treatment, respectively. However, within 
7 days following cessatio n of the 17 day treatment, the 
relative li0er weights of these animals returned t o control 
levels. 
The in vitro metabolism of Epn and p-nitroanisole was 
--- -~~ 
significantly increased in these animals as compared to 
controls. As illustrated in Table 12 and 13, the greatest 
increases in enzyme activity occurred within the first four 
days of treatment. EPN metabolism was maximum on the 8th day, 
where it was 185 percent of control, and had decreased some-
what by the 17th day to 169 percent of control. Return to 
control levels occurred within 7 days of cessation of treat -
ment. p-Nitroanisole metabolism increased co nti n~ally 
throughout the period of treatment (Table 13), and did not 
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TABLE 11. Effect of pyrethrum, 500 mg/kg/day orally, on 
liver we ight to body we ight ratio 
Days of Day of Liver/Body (g/kg) ±. SE (N) Treatment Sacrifice Control Treated 
L~ 5 51,.4 ±. 1.4 (4) 75 .. 9 ±. 0.3* * ( 4 ) 
7 8 46.9 
.±. 0.6 (4) 74.0 ±. 1. o -x- -J<- (4) 
17 18 47.2 
.±. 0.8 ('4) 75.4 .±. 1.9** (4) 
17 24 40.5 ± 2,. 0 ( 8) 38.0 ± 0.8 ( 3) 
--
-r•*P:f0 9 01, as compared to control values,. 
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TABLE 12. Effect of pyr ethrum, 500 mg/kg/d a y orally, on the 
detoxificat ion of EPN by 9 1 000 x g supernatants 
Days of Day of p-nitrophenol formed 
Treatment Sacrifice nmoles/m g protei n/60 min 
IYI ean -1· SE (N) 
Control Treated 
4 5 8.9 ±. 0.2 ( 4) 15. 2 ±. 1,,2** (4) 
7 8 11.8 ±. 0,.5 (4) 21 .o-9 ;±. 0.9** (4) 
17 18 9.8 .±. 0.2 (4) t.,6 0 7 ±. 1 ... ,0*-li- (4) 
17 24 11.8 ±. 0.8 ( 4) 1.1 ... 5 ±. 0_..4 (4) 
**P!:0.01, as compared to control values. 
f~ ·:\ ... 
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TABLE 13~ Effect of pyrethrum, 500 mg/kg/day orally, on dsmeth-
ylation of p-nitroanisole by 9,000 x g supernatants 
Days of ~ay of p-r.itrophenol formed 
Treatment Sacrifice nmoles/mg profein/60 min 
Mean 
.±. SE (N) 
Control Treated 
4 5 13~4 ±. o. 4. ( 4) 20.1 ;!. 0.7** (4) 
7 8 18.9 j-_ 0~9 ( 4) 30.2 ±. 3.1** (4) 
17 18 1 2. 4 . .±. 0.7 (4) 22.2 ±. 0.7** ( 4) 
17 24 13.7 ±. 1 ... 0 (4) 14.6 ± 1.2 ( 4) 
-K-*P:Oo 01, as compared to control values. 
appear to reach maximum levels on the 17th day where it was 
179 percent of controls. Return to control levels occurred 
within 7 days of cess atio n of treatmgnt. 
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In order to deter~ine if these changes were part of a 
generalized increase in cellular metabolism or were more 
specific, the in vitro oxidation of tryptophan was examined 
(Table 14). The tryptophan pyrrolase activities of 9,000 x g 
supgrnatants from livers of the 7 and 17 day treated animals 
were assayed and found to be not significantly different from 
controls (P =0.05). 
Components .9.f. microsomal Electron Transport System 
In order to account for the increase in microsomal 
drug metabolizing activity, components of the microsomal 
electron transport system were examined for possible increase 
in activity. Significant increases were found in the NADPH 
dependant cytochrome c reductase activity of microsomes from 
livers of animals employed in the time-effect study (Table 15 
and Figur8 3). With increasing d~ration of treatment, this 
activity was increased by 38, 54 and 27 percent on day 5 1 7 
and 17, respectively, but returned to control levels within 
7 days aft er cessation of treatment. 
Cytochrome P-450 levels of pyrethrum and corn oil treated 
animals were examined. Rats were treated with pyrethrum, 500 
mg/kg/day or corn oil for 4 days (Table 16). As correlates, 
liver to body weight ratios and microsomal drug metabolizing 
activities were measured. In compa ri son to controls, relative 
liver w3ights were increased to 141 percent while the in vitro 
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TABLE 14. Effect of pyrethrum, 500 mg/kg/day orally, on the 
oxidation of L-tryptophan by 9,000 x g supernatants 
Days of kynurenine formed 
TreatmEnt nmoles/mg protein/60 min 
!YI ean ±. SE (N) 
Control . Treated 
7 22.3 ±. 3 .. 4 ( 4) 21~5 ±. 1.4 (4) 
17 34,.1 ± 1. 7 (4) 33.7 ±. 1 0 1 (4) 
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TABLE 15 . Effect of pyrethrum, 500 mg/kg/day orally on NADPH -
cytochr ome c reductase activity in liver microsomes 
Day s of Da y of nm oles/mg protei.n/min 
Tre atmen t Sacrifice 
Mean ±. SE ( N) 
Control Treated 
4 5 88.4 ±. 6.2 ( 4) 120.8 ±. 6.8** (4) 
7 8 72.3 ±. 4. 1 ( 4) 112.6 ± 5. 2*.;(• ( 4) 
17 18 190.9 ±. 4.8 ( 4 ) 241.8 ±. 11. 8** (4) 
17 24 7 Lf • 7 ±. 3.2 ( 3 ) 74.7 ;,!-_ 5.8 (4) 
**P~D.01 as comp ared to cont ro l values . 
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TABLE 16. Effect of pyrethrum, 5PO mg/kg/day orally for 4 days, on components of 
the NADPH-linked electron transport system in liver microsomes and EPN 
detoxification and p-nitroanisole demethylation by 9 1 000 x g supernatants 
IYlean ±. SE (N) 
Control Tre ated 
EPN 
p-nitrophenol formed 
nrnolss/rng protein/60 min 7.5 ±. 0~3 (4) 13. 5 ±. 0 .. 8*-1<· ( 4) 
p-Nitroanisole 
p-nitrophenol formed 
nmoles/mg protein/60 min 12.1 ;±. 0.6 (4) 18.4 .±. 0.8** (4) 
NADPH-Cytochrome c Reductase 
nmoles/mg protein/min 189.0 ±. 15.3 (4) 372.2 ±. 19.4** (4) 
Cytochrome P-450 ~ 
2. q (.4) 51.0 ±. 3.,.8** (4) E( 450 _500 )/mg protein x 1n- . .. 33.8 ±. 
**Pf0.01, as compared to control values. 
Ul 
(.,J 
54 
metabolism of EPN and p-nitroanisole by 9,000 x g supernatants 
was increased to 181 and 14J percent, respectively. NADPH 
dependant cytochrom e c reductase levels were incre a sed to 197 
percent of control while cytochrome P-450 lev e ls we re increased 
to 141 percent of controls. 
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V. DISCU SSION 
Liver enlargem e nt due to chronic administration of drugs 
with var ying ch emi cal and biological characteri s tics i s of 
interest not only for toxicologica l studies but also for 
studies of the regul at ion of all growth and cell divi sion~ 
In th e absence of irr evers i ble pathological damage , the toxi-
cological significance of this phenom~non cannot be assessed 
until more is known of the essential natur e of the enlargement, 
as well as the ini t ial r eactions, mechanisms, and the effect 
the drug has on liver met a bo lism. 
Analyses were carri e~ out to determine if the pyrethrum 
induced liver weight increases were due to fat deposition , 
edema, proliferation of specific subcellul ar particl es , a 
coordinated growth of the whole cell (true hypertrophy) or 
an incre ase in the num ber of cells (hyperplasia). 
Control animals received a volume . of corn oil vehicle 
equal to the total volume of pyr~thrum solution administered 
in ord e r to avoid liver weight or body we ight ch anges due to 
differences in diet. 
Measurem en t of water and lipid concentrati ons (Ta ble 1) 
sho wed that th e liver weight incr eases we re nffit due to fat 
deposition er edema . If ed e~a or f a t deposjtion was the 
principal cause of th e en l argement , measurement of protein 
co ncen tr at ion of wh ole liver homogenates and su b-fractions 
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should have indicated this through dilution of protein per 
unit liver. No dilution of protein concentration was observed 
(Table 2), while measurement of lipid and water concentrations 
provided direct confirmation of the lack of edema or fat depo-
sition. 
Liver fractionation provided information ~n the cell-
physiological aspects of the enlargement. The 9,000 x g 
supernatant fr act ion contains mainly microsomes and cell sap 
since whole cells, debri s , mitochondria and nuclei are removed 
by sedimentation at this centrifugal force. Microsomes wEre 
isolated by sedimentation at 10 5 ,000 x g. Lack of alterations 
in protein concentrations of thes e fractions indicated that 
the liver weight incre ases were not due to proliferation of 
microsomes. 
The question of whether hypertrophy or hyperplasia 
caused the increase in liver ~eights w2s examined through 
measurement of D~A conce ntrations and microscopic examination 
of liver sections. Increases in liver weight combined with 
decre2ses in liver DNA concentrations are indicative of cellular 
hypertrophy. Increases in liver DNA concentrations are sug-
gestive of hyperplasia with a predominance of imm a ture cells. 
As seen in Table 2, DNA levels were found to be decreased by 
approximately 30 percent on a per gram of liver basis as com-
pared to a 30 percent rise in total weight. Altough suggestive 
of hyp ertr ophy, a ~ixture of hyp er plas ia with immature cells 
and hypertrophy might have yi elded the same percentage ch anges . 
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Examination of liver sections showed a predominance of enlarged 
cells with a slight incr eas e in mitotic divisions and smaller, 
immature cell s . These studies suggested tha t . the _iver weight · 
increases resulted primarily from a coordJnated growth of the 
whole cell. 
While the chemical constituents of the livers of treated 
animal s and of cont rols were similar, one could not necessarily 
conclude that normal and pyrethrum induced liver gro wth is 
identical. Whole tissue is employed in ch emical determinations 
of various cell constituents, such as lipid and protein, and 
does not t a ke into consideration functional variation of sub-
cellular components. With normal ~iver growth, the increase 
in total protein should show a proportionally constant rise 
in all liver erzymes. The increa se in total protein accom-
panying pyrethr~m induced liver enlar~ement was subjected to 
a more detailed etudy. Possible alterations in microeo ma l 
drug metabolism were first examined in vivo followed by exam-
inati on of microsomal and cytopl asm ic enzymes in vitro. 
Duration of hexo barbital narcosis, which is limited by 
its metabolism in hepatic microsomes (Cooper and Brodie , 1955) 
was decreased in pyrethrum treated animals (Table 3). · The 
onset and duration of narcosis due to barbital, which is 
ex creted unmetabolized (Dorfman and Goldbaum, 1947; Mayn~rt 
and Van Dyke, 1958: Ebert .§l ~' 1964), was unaffe cted by 
pyrethrum pretre a t~ent. These da ta suggested that th 0 decreases 
in hexobarbital narcosis resulted from an increas e in micro -
somal drug metabolism r at her than alterations in central 
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nervous system sensitivit yo This idea was further sub sta n-
tiated by the l ack of differences in hexobarbital serum levels 
at return of ri ghting r eflex in the two groups (T ab le 4). 
The study was cont in ued wit h an examination of in vitro 
mic r os oma l drug metabolism in order to determine if the 
decrea ses in he~obarb ital narc osis resulted only from an 
increased metabolic cap 2cit y of a larger liv er or wa s comb ined 
with incre ases in spec i fic enzymatic activity. Measurement 
of aminopyrin e N-demethylase activity was chosen as a possible 
indicator of altered wicrosomal drug metabolism since its 
meta bolism is increas ed by two prototypes of inducing agents , 
3-w.ethylch olanthr ene end phenobarb ital~ The N-demethylation 
of aminopyr ine was found to be unaltered by pyrethrum treat-
ment (Table 5) . The N-demethylation of p-chloro-N-methyl-
aniline was also found to be unaltered by pyrethrum treat-
ment (Table 6) . 
Since the decrease in hexobarbital narcosis ~ithout a 
concomitant alteration in barbital narcosis sugges te d an 
increase in microsomal drug metabolism, even though there 
were no incre a ses in the N-demethylation of p-chlorom~thyl­
aniline or aminopyrine, the in vitro metabolism of hexobarbital 
was examined. Tables 5 and 7 sho w that in vitro hexobarbital 
oxidas e activity was elevated by pyrethrum treatment. 
In his revi e w, Conney (1967) drew a di st inction between 
the selective ind uction effects of the poly cyclic hydrocarbons, 
which ind uce only a few activities such as zoxazolamine 
hydroxyl ase and azo dye demethylase bu t not hexobarbital oxid Gse 
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or aminopyrine demethylase, and the generalized inductive 
effect of ph e nob arbita l which induces all fo ur a ctivities. 
Becau se of the se otservations, the lack of incr ease in amino-
pyrine dem et hyl ase WES subjected to a more detailed study. 
Samples that showed no incr ease in aminopyrine demethylase 
activity when assayed for formaldehyde production at 60 min 
were pooled in pairs and in duplicate determinat ions, assayed 
for formaldehyde production at 10, 20 and 30 min. As shewn 
in Figure 3, there was no significant difference between 
pyr ethrum treat e d and control animals in the prodcction of 
formald eh yd e at 10, 20 and 30 min , although the rate was 
approximately line ar for only 30 min. 
This work confir~ed that of Soyka (1969), who noted that 
even if linearity for 15 min was accom plished, the use of too 
small a qcantity of glucose-6-phosphate limited the production 
of formaldehyde. Thus the activity of adult liver erroneously 
appeared to be less than that from 20 day old animals if 
studied after 30 min of incubation. 
The increase in hExobarbital oxidase activity withoct 
an increase in aminopyrine demethylase activity suggested 
that pyrethrum did not resemble in effects produced either 
prototype of enzyme inducer . It is interestirig to note that 
in studying th e structure activity relationships of substituted 
phenols on liver we ights and liver enzymes in the rat, Gilbert 
~ ~ (1969) found there was no dirEct relationship between 
liver weight increases and incr eases in hexobarbital oxidase 
and aminopyrine demethyl ase acti viti es , Cert a in compc unds 
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consi stently showed a greater effect on aminopyrine demethylase 
than on hexobarbital oxidase while the reverse also occurred. 
Th ey further found that 2,6-di-tert-butyl-4-hydroxymethyl-
phenol induced hexobarbital oxidase strongly with no corre-
sponding increase in the activity of aminopyrine demethylase . 
This new catego~y appears td exemplify the effects of pyrethrum. 
In order to further categorize the effects of pyrethrum, 
other microsomal enzymes were examined for alteration in 
activity, including p-nitroanisole 0-demethylase and EPN detox-
ification. Table 7 shows that the activities of both of these 
enzyme s were increasedo 
At this point it was of interest to determine if these 
incr eases in drug metabolizing activity were part of a gener-
alized increase in cellular metabolic activity or were mere 
specific as suggested by the lack of increase in aminopyrine 
N-demethylase and p-chloromethylaniline N-demethylase activi-
tieso Lack of increase in tryptophan pyrrolase activity 
(Table 14), an enzyme localized in the 105,000 x g supernatant 
fraction and therefore a probable cytoplasmic enzyme, further 
supported the hypothesis that the enzymatic increases were 
specific in nature, indicative of true enzyme induction. 
Investigation of liver enlargement and increases in drug 
metabolizing activities due to pyrethrum was continued with 
establishment of a dose-effect relationship (Figure 2). The 
results of this study indicated that increases in enzyme 
activity ware evident before liver enlargement. Increases in 
enzyme activity paralleled the liver enlargement . These 
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parameters increased in a logarithmic fashion with increasing 
dos ages indicat ing a dose-effect rel at io nship . Th e data also 
sug~ested that tha maximum re sp ons e of the parameters had not 
been re ached , although higher dos es are within th a lethal 
range of pyrethru m. 
An investiga tion was also undertaken to s~udy the time 
course a nd reversibility of these changes (Fig~re 3). Liver 
enlargemen t and p-nitroanisole metabolism increased with 
increasing duration of treat men t. The greatest increase 
occurred during the first four days of treatment, with smaller 
increases at the next consecutive measurements, suggesting the 
attainment of a plateau of peak activity after ab~ut 2 weeks 
of treatment. EPN de toxification and NADPH-cytochrome c 
reductase activity paralleled each other in activity. The 
greatest increas e in activity occurred during th e first four 
days, b~t unlike the time course of p-nitroanisole ~etabolism 
and liver enlarg ement , it was maximum on the 8th day and had 
declined so~ewhat by the 18th day. Martin and Gilbert (1968) 
and Gilbert et~ (1969) recog ,1ized that continued administra-
tion of a compounj could lead to regression of the initial 
effect . These studies suggest that increasas in liver size 
cannot necessarily be equated with increases in enzymatic 
activity . 
All parameters measured, returned to control levels within 
7 days after ces sat ion of treatment showing that the changes 
are spontaneously reversible upon discontinuation of exposure 
to pyrethrum. 
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True enzyme inducers, stimulants of hepatic microsomal 
drug metabolism, have the abilit y to increase components of 
the microsomal electron transport system. For example, 
pheno barbital and 3-~ethylcholanthrene cause increases in 
P-450 conce ntrations, and phenobarbital increases th 3 activity 
of NADPH-cytochrome c reductase (Conney, 1967). These obser-
vatio ns suggested that pyrethrum may have a similar inductive 
effect on these components of the microsomal electro~ trans-
port, and consequently be a true enzyme inducer. As shown 
in Tables 15 and 16 and Figure 3 , both of these components 
are elevated by pyrethrum treatment . 
It sh ou ld be noted that the magnitude of the doses 
employed in this study would not be encountered in normal 
usage of pyrethrum. However, this study does not indicate 
a no-effect level for py:ethrum. 
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VI. SUMMARY AND CONCLUSIONS 
1, Liver enlargement due to pyrethrum is associated with 
proportional increases in total water and total protein 
of whole liJer, 9,000 x g supernatant fraction and 105,000 
x g pellets. Statistically significant (Pf0.0 5 ) increases 
in total lipid .per gram of liver did not account for th3 
total incr ease in liver weight. The en lar gement was 
further associated with a decrease in DNA per gram of 
/ 
liver, suggestive of hypertrophy. Microscopic examination 
of liver sections supported this hypothesis. 
2. Liver enlargement due to pyrethrum is associated with a 
decrease in hexobarbital induced narcosis. Hexobarbital 
serum levels at awakening were not significantly different 
in control and pyrethrum treated animals . The onset and 
duration or barbital narcosis was not significantly al t ered 
by the pyrethrum pretreatmento These results suggested 
that the decrease in hexabarbital induced narcosis was due 
to increas ed microsomal metabolism of the drug rather than 
a ch ange in CNS sensitivity to the drugo 
3. In vitro increases in specific microsomal oxidation of 
hexobarbital, 0-demethylation of p-nitroanisole and detox-
ification of EPN were associated with ~he liver enlargement. 
Th e observed lack or increase in specific activity of 
aminopyrine demethylase did not result from the duration 
of incubation employed in the assa y, although the pro -
duction of form a ldehyd e was not linear for 60 min jut 
linear for at l east 30 min. 
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4. ]..!2 vit ro tryptophan pyrrolase activity , a 105,000 x g 
sup ernatant enzyme , was not significantly altered by 
pyr ethrum t~eatment. The lack or i ncrease in this enzyme , 
as well as th e l ack of increases in aminopyrine N-d eme thylase 
and p-chlorornethylaniline N-demethylase, suggested that 
the increases in microsomal drug metabolism were not part 
of a generalized increase in c e ll ular metabolism . 
5. Incr eases in liver to body weight ratios and incre a3e s in 
met abolism of p-nitroanisole and of EPN by 9,000 x g super-
natants were found to be dose rel ated . At the lo wast dose 
us ed of 85 mg /kg, increases in microsomal drug metabolism 
wer e evident before liver enlargement . Peak c ctivity of 
th ese parameters was not apparently r eached at the highest 
dose used of 500 mg/kg, although higher doses were within 
the leth a l range of pyrethrum. 
6. Incr eases i n liv ar to body weight ratios and incre a ses in 
metabol ism of p-nitroanisole and of EPN by 9,000 x g s uper -
natant s were found to be time rel ated . The g~eatest 
increases in the3e parameter s occurred within the first 
four days of treatment, but did not appear to re a ch plateau 
l evels simultaneously. The incre ase in NADPH-cytochrome c 
r eductase , a component of the microsomal electron trans-
port system , was also time rel ated . It is import ant to 
no te th a t all parameters measured return ed to control 
levels within 7 days after cessation of treatment, 
suggesting that irreversible changes had not occurred. 
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7. Increases in P-450, a component of the microsomal electron 
transport system, were associated with increases in liver 
to body weight ratios and increases in EPN detoxification, 
p-nitroanisqle demethylase and NADPH-cytochrome c reductase. 
8. These findings are consistent with and support the hypoth-
esis that pyrethrum caused liver enlargement results from 
true hypertrophy. It is proposed that increases in specific 
microsomal drug metabolizing activity , as well as an 
incre ase in metabolic capacity resulting from the larger 
liver, account for the decrease in hexobarbital induced 
narcosis. It is proposed that the increases in specific 
enzyme activity result from the synthesis of new protein 
and that in fact, pyrethrum is a true enzyme inducer. 
These data suggest the need for further investigation to 
reevaluate the use of pyrethrum as a non-inducing insecti-
cide. 
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